{
  "module_id": "dpyd_fluoropyrimidines",
  "category": "pgx",
  "display_name": "Fluoropyrimidine toxicity markers (DPYD)",
  "rsids": ["rs3918290", "rs55886062", "rs67376798", "rs75017182"],
  "rules": [
    {
      "rsid": "rs3918290",
      "genotypes": ["AA", "AG", "GG"],
      "summary": "DPYD variants are used clinically to assess risk of fluoropyrimidine toxicity. This marker is one of several variants used in guidelines."
    },
    {
      "rsid": "rs55886062",
      "genotypes": ["AA", "AG", "GG"],
      "summary": "DPYD variants are used clinically to assess risk of fluoropyrimidine toxicity. This marker is one of several variants used in guidelines."
    },
    {
      "rsid": "rs67376798",
      "genotypes": ["AA", "AG", "GG"],
      "summary": "DPYD variants are used clinically to assess risk of fluoropyrimidine toxicity. This marker is one of several variants used in guidelines."
    },
    {
      "rsid": "rs75017182",
      "genotypes": ["AA", "AG", "GG"],
      "summary": "DPYD variants are used clinically to assess risk of fluoropyrimidine toxicity. This marker is one of several variants used in guidelines."
    }
  ],
  "default_summary": "No call or unrecognized genotype for DPYD markers.",
  "suggestion": "If you receive fluoropyrimidines (e.g., 5â€‘FU/capecitabine), discuss pharmacogenomic testing with a clinician. Do not change medications based on this app.",
  "evidence_level": {
    "grade": "A",
    "summary": "CPIC guidelines exist for DPYD and fluoropyrimidines."
  },
  "limitations": "Many DPYD variants are rare and not captured by SNP chips. This is not a clinical test or dosing advice.",
  "references": [
    "CPIC guidelines for DPYD and fluoropyrimidines (PharmGKB/CPIC)",
    "AncestryDNA raw data format documentation"
  ]
}
